Image: fernandozhiminaicela, via Pixabay
Pilot programme to advise developers of treatments and diagnostics for rare diseases
The European Medicines Agency has introduced a pilot programme to support the development of devices to treat or diagnose rare diseases.
Announced on 2 August, the EMA pilot programme will offer free advice to selected manufacturers and accredited assessment bodies on the status of ‘orphan’ devices and the data required for their clinical evaluation.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.